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Backround/aim: In prostate cancer, extraprostatic extension (EPE) is an unfavorable prognostic factor, and the grade of EPE is
correlated with the prognosis. This study aims to evaluate the utility of length of capsular contact (LCC ) in predicting the grade of EPE
by correlating the measurements from MRI images and the measurements performed from radical prostatectomy specimens.
Materials and methods: MR images and specimens of 110 tumors are analyzed retrospectively. The specimens are used as reference to
validate the presence of EPE and to measure the ground truth LCC. MR images are evaluated by two radiologists to identify the presence
of EPE and to predict the LCC indirectly. Reliability, accuracy, sensitivity, and specificity of the evaluations are analyzed in comparison
with the findings obtained from the specimens.
Results: In detection of EPE existence, the radiologists achieve almost the same performance (all AUCs = 0.73) with optimal cut-off
values lead to moderate sensitivity and specificity pairs (For cut-off = 15.8 mm; Se = 0.69, Sp = 0.68 and for cut-off of 14.5 mm: Se =
0.77, Sp = 0.62). In distinguishing high-grade EPE from low-grade EPE, the radiologists accomplish very similar performances (AUCs
= 0.73 and 0.72) Optimal thresholds of 20.0 mm and 18.5 mm for the readers retrospectively reveal medium sensitivity and specificity
pairs (Se = 0.64, Sp = 0.67; Se = 0.64, Sp = 0.67).
Conclusion: Consistent LCC estimates can be obtained from MR images providing a beneficial metric for detecting the existence of EPE
and for discriminating the grades of EPE.
Key words: Prostate cancer, extraprostatic extension, length of capsular contact, tumor grading, multi-parametric magnetic resonance
imaging

1. Introduction
Accurate local staging of prostate cancer is crucial for
determining the prognosis and establishing the best
treatment plan [1–3]. The staging is highly influenced by
the status of extraprostatic extension (EPE). Moreover, a
greater EPE is associated with a significant prognosis of
the disease. It has also an impact on surgical strategy by
modifying the surgical technique, i.e. performing a wider
margin of excision versus narrower margin of excision that
depends on the amount of EPE. In the case of a high amount
of EPE, the patient can be informed about the increased
risk of positive surgical margin, and neoadjuvant therapy
can be considered. Besides, such a patient can be treated
with radiation therapy or hormone therapy before surgery
or instead of surgery. In detecting EPE and determining
the amount of EPE from pathology specimens, several subclassification methods are proposed [4–7]. However, there

has been no common consensus for the optimal method
and sub-classification categories are exempted from the
2010 tumor node metastasis (TNM) staging system [8]. In
addition to this, there is a great need for a less complicated
and easy to use technique to detect EPE presence and to
predict the amount of EPE.
Multi-parametric magnetic resonance (MR) imaging
is the most favorable imaging technique for local staging
of prostate cancer [9–11] and also offers many imaging
findings linked to EPE. When compared to the findings
from clinical examination, the findings from the images
are demonstrated to be more beneficial in expressing EPE
[12,13]. Nevertheless, a recent meta-analysis shows that
MR imaging-based local staging of prostate cancer shows
high specificity with low sensitivity [14]. ‘A tumor-capsule
interface of greater than 1.0 cm’ is an MR imaging finding
introduced in the prostate imaging-reporting and data
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system version 2.1 (PIRADS V2.1) guideline that linked to
EPE [15]. The tumor-capsule interface, also named as the
length of capsular contact, measured as the tumor contact
length with prostate capsule on the images establishes a
good agreement and performance [16–22]. However, the
relationship between the length of capsular contact and
the amount of EPE has not been understood fully yet.
The current study aims to figure out the utility of
length of capsular contact (LCC) from MR images in
detecting and grading the extraprostatic extension (EPE)
for prostate tumors in comparison with the measurements
performed on radical prostatectomy specimens.
2. Materials and methods
2.1. MR Imaging of the prostate and radical prostatectomy
intervention
Institutional review board approval and informed consent
are secured for this retrospective study. A search on the
electronic databases at our institution explored a total of
121 prostate tumors from 121 patients who underwent
MR imaging before radical prostatectomy intervention.
Unreachable pathology records were of concern for four
tumors. The time interval between the imaging and the
RP was longer than six months for five cases. MR images
of the two tumors were with severe artefacts. These
tumors were excluded from the study and the remaining
110 tumors were taken into consideration (various
imaging features from these tumors were reported in
our previous work focused on assessment of the grade of
extraprostatic extension of the prostate carcinoma [23];
however, the current study targets the length of capsular
contact feature for the first time). In addition, a portion
of the study population (approximately 70%) was used to
evaluate whether the International Society of Urological
Pathology (ISUP) grade group of the tumors influenced
the relationship between LCC and EPE presence (ref);
however, for the first time, we analyzed the role of LCC in
assessment of the amount of EPE with a larger study group
in our current study.

MR imaging of the prostate is conducted with a 3T MRI
scanner (Magnetom Skyra, Siemens Medical Solutions,
Erlangen, Germany) and a sixteen-channel phased-array
surface coil in a multi-parametric manner. To reduce
motion artifacts associated with bowel peristalsis, imaging
is performed after intramuscular injection of 20 mg of
butylscopolamine (Buscopan, Boehringer). The imaging
protocol respectively consists of T2-weighted imaging
(T2WI), fat-suppressed dynamic contrast-enhanced
imaging (DCE), free-breathing diffusion-weighted
imaging (DWI), and apparent diffusion coefficient (ADC)
mapping with the imaging parameters listed in Table 1.
Following imaging, radical prostatectomy interventions
are performed. All of the specimens gathered are fixed
with 10% buffered neutral formalin, then surgical margins
are painted with ink. The entire prostate gland and seminal
vesicles are step sectioned from apex to base at 3–4 mm
intervals in the plane perpendicular to the long axis of
the prostate gland, and hematoxylin and eosin are used to
stein these sections. An index lesion is marked according
to the following benchmarks; 1: the prostate tumor foci
that show EPE, 2: the prostate tumor foci that have the
highest ISUP grading score, 3: the tumor foci that have the
largest dimension.
2.2. Prediction of the length of capsular contact
For an index lesion identified, the absence or presence EPE
and the pathologic length of tumor capsule contact on the
RP specimen (p-LCC) are determined by an experienced
uropathologist. In the presence of EPE, the pathological
radial distance of EPE (p-RD), defined as the length of
tumor protrusion perpendicular to the outer margin of the
prostatic stroma, is measured additionally (in the existence
of multiple foci of EPE, the measurement is done from the
focus with the maximum extension). The index lesion is
matched with a histopathological diagram as reference
standard with the consensus of the uropathologist and two
radiologists by taking into account of alterations on the
shape and size of the prostate caused by the preservation
of specimens.

Table 1. MR imaging sequences and sequence dedicated parameter values are summarized.
Sequence

Imaging plane

TR/TE (ms)

FOV
(mm2)

ST/Gap
(mm)

Matrix size

T2W (TSE)

Axial, Coronal and Sagittal

3566–3631/100

200 × 200

3.0

512 × 352

DCE (GRE)

Axial

4.86/1.76

260 × 260

3.6

192 × 154

DWI (SS-EPI)

Axial

4000/101

260 × 260

3.6/0.3

192 × 154

TR: Repetition time, TE: Echo time, FOV: Field of view, ST: Slice thickness, TSE: Turbo spin echo, GRE: Gradient
recalled echo, SS-EPI: Single-shot echo-planar imaging with b-values of 0, 50, 100, 200, 400 and 800 s/mm2 with
automatic apparent diffusion coefficient mapping and computed high b-value mapping for b = 1500 s/mm2.
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The two radiologists have 12 and 5 years of experience
in genitourinary radiology (B.B and A.O). They
independently explore all MR images using DynaCAD
prostate software (version 3.3, Philips Healthcare). Each
radiologist identifies the dominant prostate tumor foci
with low signal intensity on ADC maps and high signal
intensity on high b-value DWI images with or without
early contrast enhancement on DCE images. Next, the
radiologist measures the length of the tumor capsule
interface (MR-LCC) on the axial T2W image according to
the method described by Baco et al [18] using the curved
measurement tool offered by the software. If the radiologist
cannot manage to identify any contact between the tumor
and the capsule on the images, MR-LCC is considered to
be zero. During measurements, the radiologists are aware
that the patients have prostate cancer verified by radical
prostatectomy, but they are blinded to the demographical,
clinical, and final pathology findings.
2.3. Statistical analysis
Mann–Whitney U test or independent-samples t-test is
conducted to detect significant differences in the LCC
estimates for the tumors with and without EPE and for
the tumors having high and low grades of EPE. Spearman
Rho (ρ) is used to assess the correlation between the p-RD
and the LCC estimates and between p-LCC and the LCC
estimated from MR images. The inter-observer agreement
for the MR-LCC estimates across the radiologists is

determined using the intraclass correlation coefficient
(ICC). Performances of the LCC estimates in the diagnosis
of EPE and in distinguishing the low-grade EPE from highgrade EPE are obtained by performing receiver operator
characteristic curve analyses and by calculating the area
under the curves (AUC). Youden analysis is implemented
to obtain the optimal threshold for the LCC, and the
sensitivity (Se) and specificity (Sp) are reported for that
threshold. A p-value of <0.05 is considered for statistical
significance. All analyses are performed using IBM SPSS
for Windows (v25; IBM Corp., Armonk, NY, USA).
3. Results
Radical prostatectomy specimens and multi-parametric
MR images of 110 prostate tumors diagnosed with
prostate cancer are evaluated retrospectively. The mean
time interval between the imaging and the intervention
is 73.1 days (range: 11–192 days). Organ-confined disease
is acknowledged for 84 tumors, and EPE is detected for
the remaining 26 tumors from the specimens. The radial
distance of the extension (p-RD) measured from the
specimens of the EPE positive tumors gives a median value
of 1.0 mm that is later used as a cut-off to categorize the highgrade and low-grade EPE positive tumors. Consequently,
among the 26 EPE positive tumors, 15 tumors are figured
out to be with low-grade EPE and 11 tumors are with highgrade EPE. Figures 1a–1c and Figures 2a–2c demonstrate

Figure 1a. A prostate tumor on the left lateral peripheral zone with a Gleason score of 3+4 is seen. Axial T2 weigheted image
shows the index lesion matched with radical prostatectomy specimen. Pathological analyses revealed p-RD = 0.5 mm and
p-LCC = 15 mm while the radiologists respectively report MR-LCC1 = 15.2 mm and MR-LCC2 =16.0 mm.
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Figure 1b. A prostate tumor on the left lateral peripheral zone with a Gleason score of 3+4 is seen. Axial ADC map shows the index
lesion matched with radical prostatectomy specimen Pathological analyses revealed p-RD = 0.5 mm and p-LCC= 15 mm while the
radiologists respectively report MR-LCC1 = 15.2 mm and MR-LCC2 =16.0 mm.

Figure 1c. A prostate tumor on the left lateral peripheral zone with a Gleason score of 3+4 is seen. Axial high b-value computed
diffusion-weighted image shows the index lesion matched with radical prostatectomy specimen. Pathological analyses revealed p-RD =
0.5 mm and p-LCC = 15 mm while the radiologists respectively report MR-LCC1 = 15.2 mm and MR-LCC2 =16.0 mm.
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Figure 1 d. A prostate tumor on the left lateral peripheral zone with a Gleason score of 3+4 is seen. Schematic view
of radical prostatectomy specimen demonstrates the index lesion Pathological analyses revealed p-RD = 0.5 mm
and p-LCC = 15 mm while the radiologists respectively report MR-LCC1 = 15.2 mm and MR-LCC2 =16.0 mm.

Figure 2a. A prostate tumor on the right lateral peripheral zone with a Gleason score of 4+3 is given. Axial T2 weigheted
image shows the dominant tumor foci verified with pathology. Pathological analyses revealed p-RD = 1.7 mm and p-LCC =
25.0 mm while the radiologists respectively report MR-LCC1 = 24.8 mm and MR-LCC2 = 24.0 mm.
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Figure 2b. A prostate tumor on the right lateral peripheral zone with a Gleason score of 4+3 is given. Axial ADC map shows the
dominant tumor foci verified with pathology. Pathological analyses revealed p-RD = 1.7 mm and p-LCC = 25.0 mm while the
radiologists respectively report MR-LCC1 = 24.8 mm and MR-LCC2 = 24.0 mm.

Figure 2c. A prostate tumor on the right lateral peripheral zone with a Gleason score of 4+3 is given. Axial high b-value computed
diffusion-weighted image shows the dominant tumor foci verified with pathology. Pathological analyses revealed p-RD = 1.7 mm
and p-LCC = 25.0 mm while the radiologists respectively report MR-LCC1 = 24.8 mm and MR-LCC2 = 24.0 mm.
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Figure 2d. A prostate tumor on the right lateral peripheral zone with a Gleason score of 4+3 is given. Schematic view of radical
prostatectomy specimen shows the dominant tumor foci verified with pathology. Pathological analyses revealed p-RD = 1.7 mm and
p-LCC = 25.0 mm while the radiologists respectively report MR-LCC1 = 24.8 mm and MR-LCC2 = 24.0 mm.

the measurements for the two representative tumors from
the study dataset. Tumor localizations in the RP specimens
of the same cases are shown in Figure 1d and Figure 2d.
Average p-LCC and MR-LCC estimates from all
the tumors taken into analyses are listed in Table 2, and
conforming boxplots are presented in Figures 3a–3f).
Both p-LCC, MR-LCC1 and MR-LCC2 is lower for the
EPE negative tumors than the EPE positive ones (Figures
3a–3c) and an increase in both p-LCC, MR-LCC1 and MRLCC2 is a precursor for high-grade EPE positive tumors
(Figures 3d–3f). Significant differences are present for
both p-LCC and MR-LCC between EPE negative and EPE
positive tumors and also between low-grade and highgrade EPE positive tumors (p < 0.05 at all). Table 3 shows
the correlations between MR-LCC and p-LCC from the
tumors. For EPE negative tumors, moderate correlations
are observable between p-LCC and MR-LCC estimates
by the radiologists (ρ = 0.70 and 0.67, respectively) while
slightly better correlations are noticeable between p-LCC
and MR-LCCs for the EPE positive tumors (ρ = 0.72 and
0.67). Moderate correlations present between p-LCC and
MR-LCCs both for low-grade EPE positive tumors (ρ =
0.67 and 0.62), but good correlations exist for high-grade
EPE positive tumors (ρ = 0.82 and 0.74). Very strong
correlations are noted between MR-LCC estimates by the
radiologists for all EPE cases (ρ = 0.92–0.98). Overall, very
similar MR-LCC estimates are obtained by the radiologists
(ICC = 0.97, 95% CI = 0.96–0.98). On the other hand, p-RD
shows a fair correlation with p-LCC (ρ = 0.39); however,
moderate correlations are present between p-RD and
MR-LCC estimates by the radiologists (ρ = 0.58 and 0.59,
respectively) for the EPE positive tumors. All correlations
are significant (p < 0.05).

1946

Table 2. The length of capsular contact measured from
pathological specimens and estimated from MR images (in mm)
are given.
p-LCC

MR-LCC1

MR-LCC2

EPE negative

11.0 ± 9.1

12.5 ± 7.4

12.7 ± 7.5

EPE positive

20.0 ± 10.7

20.5 ± 10.3

21.0 ± 10.7

Low-grade

16.0 ± 7.2

16.7 ± 6.7

17.0 ± 6.5

High-grade

25.5 ± 12.5

25.3 ± 12.5

26.5 ± 13.1

The performances of LCC in detecting the EPE
positive tumors and in distinguishing the low-grade from
high-grade EPE positive tumors are presented in Table 4,
and the ROC plots obtained during analyses are as seen
in Figure 4a and Figure 4b. In the detection of the EPE
positive tumors, p-LCC performs fair (AUC = 0.74), and
almost the same performance is accomplished by MR-LCC
for both of the radiologists (all AUCs = 0.73) as shown
in Figure 4a. For the optimal cut-off of 16.5mm, p-LCC
reveals fair sensitivity and moderate specificity (Se/Sp =
0.58/0.77). For the optimal cut-off values of 14.5 mm and
15.8 mm for the radiologists, MR-LCC provides moderate
sensitivity and specificity pairs (Se/Sp = 0.77/0.62 and Se/
Sp = 0.69/0.68). Higher optimal cut-off is of concern for
p-LCC achieving higher specificity but lower sensitivity
when compared to the ones for MR-LCC. In distinguishing
the low-grade from high-grade EPE positive tumors,
almost the same fair performance is delivered by p-LCC
and MR-LCC (AUCs= 0.71–73) as shown in Figure 4b.
For the optical cut-off of 21.0 mm, p-LCC gives moderate
sensitivity and specificity (Se/Sp= 0.64/0.73). The optimal
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Figure 3a. Boxplot for p-LCC from EPE negative and EPE positive tumors are demonstrated. Significant differences are present for
p-LCC (p < 0.0001) between EPE negative and EPE positive tumors. b. Boxplot for MR-LCC1 from EPE negative and EPE positive
tumors are demonstrated. Significant differences are present for MR-LCC1( p < 0.0001) between EPE negative and EPE positive tumors.
c. Boxplot for MR-LCC2 from EPE negative and EPE positive tumors are demonstrated. Significant differences are present for MR-LCC2
(p < 0.0001) between EPE negative and EPE positive tumors. d. Boxplot for p-LCC from low-grade and high-grade EPE positive tumors
are shown. Significant differences are present for p-LCC (p = 0.039) between low-grade and high-grade EPE positive tumors. e. Boxplot
for MR-LCC1 from low-grade and high-grade EPE positive tumors are shown. Significant differences are present for MR-LCC1 (p =
0.032) between low-grade and high-grade EPE positive tumors. f. Boxplot for MR-LCC2 from low-grade and high-grade EPE positive
tumors are shown. Significant differences are present for MR-LCC2 (p = 0.044) between low-grade and high-grade EPE positive tumors.
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Table 3. Correlations between the length of capsular contact estimated from MR images and measured
from pathological specimens (Correlations are significant at p < 0.01) are shown.
Spearman Rho (ρ) of
MR-LCC1 vs p-LCC

Spearman Rho (ρ) of MR- Spearman Rho (ρ) of
LCC2 vs p-LCC
MR-LCC1 vs MR-LCC2

EPE negative

0.70

0.67

0.97

EPE positive

0.72

0.67

0.96

Low-grade

0.67

0.62

0.92

High-grade

0.82

0.74

0.98

Table 4. Performances of the LCC estimates are demonstrated.

In detecting EPE

In discriminating EPE grades

AUC (95% CI)

Cut-off (mm)

Se

Sp

p-LCC

0.74 (0.64–0.82)

16.5

0.58

0.77

MR-LCC1

0.73 (0.62–0.84)

14.5

0.77

0.62

MR-LCC2

0.73 (0.61–0.84)

15.8

0.69

0.68

p-LCC

0.71 (0.49–0.94)

21.0

0.64

0.73

MR-LCC1

0.73 (0.53–0.93)

20.0

0.64

0.67

MR-LCC2

0.72 (0.52–0.92)

18.5

0.64

0.67

cut-offs of 20.0 mm and 18.5 mm for MR-LCC reveal the
same moderate sensitivity and moderate specificity (Se/Sp
= 0.64/0.67 at all). Higher optimal cut-off is of concern for
p-LCC achieving higher specificity when compared to the
ones for MR-LCC.
4. Discussion
Detection and grading of extraprostatic extension (EPE) of
prostate tumors are remarkably important for precise local
staging of prostate cancer and management of the patients
suffering from prostate cancer [4–7]. Multi-parametric
MR images offer several metrics to improve the accuracy
of prostate cancer staging. In the current study, the utility
and the reproducibility of the length of capsular contact
estimated from the multi-parametric MR images of the
prostate tumors have been assessed for the purpose.
The length of capsular contact estimated from the multiparametric MR images of the prostate tumors (MR-LCC)
is reported to be the most prevalent and relatively objective
imaging measure satisfying fair to good performances
with good inter-reader agreements in detection of EPE
existence [16,18–22]. Every 1 mm increase in the measure
is thought to be linked to a 4% increase in the risk of EPE
[19]. The optimal threshold for detection is associated with
the balance between the sensitivity and the specificity and
takes values from 6 mm to 20 mm [18–22]. In the current
study, LCC measurements performed independently by
two radiologists reveal moderate performances and very
similar optimal cut-off values (i.e. 14.5 mm and 15.8
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mm) that lead to moderate sensitivity and specificity
in the detection of EPE positive tumors. LCC estimates
from MR images offer good inter-observer agreements.
The results of the current study is in consistent with the
previous studies that reported fair performance with good
interobserver agreement rates [18–22]. We recomended
the LCC cut off value of 14.5 mm for detecting EPE in
prostate cancer.
For grading EPE for an EPE positive prostate tumor,
the radial distance of EPE, described as the length of
tumor protrusion perpendicular to the outer margin of
the prostatic stroma, has been voted as a beneficial metric.
However, several studies demonstrate that if used as a
continuous metric, the radial distance determined from
the radical prostatectomy specimens is insignificantly
correlated with prognosis. Besides, an increase in the
metric is shown to be signiﬁcantly associated with an
increase in the risk of biochemical recurrence [4,24,25].
Significant correlations can be obtained when the metric
is converted into its categorical form by performing
thresholding, and the median of the radial distance from a
large population of prostate is recommended as an optimal
threshold [24,26]. In agreement with these studies, an
optimal threshold of 1.0 mm is determined in the current
study and later used to categorize the high-grade and lowgrade EPE positive prostate tumors.
In the current study, LCC estimate from multiparametric MR images provides fair diagnostic
performance and reveals moderate sensitivity and
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Figure 4a. ROC plots for p-LCC, MR-LCC1, and MR-LCC2 in discrimination of EPE
negative and EPE positive tumors are given. p-LCC (AUC = 0.74) and MR-LCC for both
of the radiologists (all AUCs = 0.73) perform fair performance in the detection of the
EPE positive tumors.
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Figure 4b. ROC plots for p-LCC, MR-LCC1, and MR-LCC2 in discrimination of lowgrade and high-grade EPE positive tumors are given. Fair performance is also delivered
by p-LCC and MR-LCC (AUCs = 0.71-73) in distinguishing the low-grade from highgrade EPE positive tumors.
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specificity in discriminating high-grade from low-grade
EPE positive tumors with the optimal LCC cut-offs of
values of 20.0 mm and 18.5 mm. The performance of the
MR-estimated LCC in discriminating the EPE-positive
patients according to the amount of EPE has not been
previously studied. Nevertheless, the distinct cut-off
values for diagnosing any EPE (whether focal-low-grade
or established-high grade EPE) and established-high
grade EPE has been published only in one previous study
that reports the optimal thresholds of MR estimated LCC
as 6 mm for detecting EPE and 10 mm for diagnosing
established-high grade EPE [20]. When compared to that
work, higher optimal LCC thresholds are reported for
the detection and the diagnosis in the current work. This
difference can be explained by two different perspectives.
Firstly, LCC is obtained for an index lesion localized within
the entire prostate gland in the current study, while it is
measured for the dominant lesion localized within each
of the lobes of the prostate gland in [20]. Secondly, while
the cut-off value of pathological RD was taken as 0.5 mm
for classifying patients as focal versus established in [20].,
the current study reports the cut-off value of 1.0 mm for
pathological RD to discriminate the high-grade EPE from
the low-grade EPE. The median value of the pathological
RD obtained from a patient population is recommended
for use as a cut-off for discriminating the high-grade
from the low-grade EPE positive tumors. A threshold
value of 1.0 mm is obtained in the current study that is
in accordance with some previous studies one of which
enrolls the largest study cohort of EPE positive tumors
and utilizes 1.0 mm cut-off as the optimal threshold for
RD that is signiﬁcantly associated with the increase in
BCR risk [24–26]. We recommend the LCC cut off value
of 18.5 mm for distinguishing low grade EPE from high
grade EPE.
The results of the current study note a moderate
correlation between pathological RD and the MR estimated
LCC, while a poor correlation is demonstrated between
pathological RD of EPE and pathological LCC. This is an
unexpected finding that required an explanation on whether
there is a significant difference between pathological LCC
and MR determined LCC measurements according to the
EPE status. We observed that pathological LCC and MR
determined LCC measurements are highly correlated in all
groups when patients are classified according to EPE status.
However, this correlation is much stronger in patients with
a high amount of EPE than in patients with a low amount
of EPE (Table 3 ). Bakır et al. reports that, in the low ISUP
grading group, the pathological LCC and MR estimated
LCC measurements are less concordant, and statistical
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results involving the LCC and EPE relationship for
pathological LLC and MR estimated LCC measurements
are diverging [23]. Considering more aggressive tumors
with higher ISUP grading group shows a higher tendency
to extension beyond the prostatic capsule; the findings of
the current study is in accordance with the literature. LCC
measurements from MR images may be overestimated or
underestimated for less aggressive prostate tumors, and this
might cause lower correlations with LCC estimates from
radical prostatectomy specimens. Tumor aggressiveness
may play a role in establishing the relationship between
LCC and EPE.
There are some limitations of the current study. The
study has a retrospective design, and this may lead to
some selection bias for the prostate tumors taken into
analysis. The study dataset covers a large number of
prostate tumors, but the number of EPE positive tumors
in the dataset is limited. Consequently, the results reported
may not be generalized well for the EPE positive tumors.
Although MR images of the prostate tumors are with high
quality, the length of capsular contact may be under- or
over-estimated especially for less aggressive tumors due to
resolution margins of the recent MR imaging technology.
In conclusion, multi-parametric MR images deliver
reliable estimates of the length of capsular contact for
prostate tumors that can be used in detecting and grading
extraprostatic extension for the tumors in local staging
of cancer and selection of appropriate surgical plan. We
suggested further prospective studies with larger study
cohorts to clarify potential benefits, and computational
tools are needed to be developed to promote the use of
MR-derived length of capsular contact in clinical practice.
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